Dr. John Winkelman On Treating Sleep Disorders
The Carlat Psychiatry Report, Volume 2, Number 10, October 2004
John W. Winkelman, M.D., Ph.D.
Assistant Professor of Psychiatry, Harvard Medical School
Medical Director, Sleep Health Center, Brigham & Women’s Hospital
Dr. Winkelman has disclosed that he has received research grants from Boehringer- Ingelheim, GlaxoSmithKline, Pfizer, UCB Pharma, and Xenoport, that he has served as a consultant for Boehringer-Ingelheim, Cephalon, GlaxoSmithKline, Pfizer, Sanofi, and Sepracor,, and is a member of the speakers bureau of Cephalon, Eli Lilly, GlaxoSmithKline, and Sanofi.
Dr. Winkelman, could you recommend a practical approach for psychiatrists diagnosing sleep disorders?